4/A
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000008
Options or other derivatives
- President and CEO acquired 149,965.43 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Parikh Anand Kiran President and CEO | 2026-02-17 | Grant or award · Series B Preferred Stock | +761.43 | 761,428 | D | ||
| Parikh Anand Kiran President and CEO | 2026-02-17 | Grant or award · Employee Stock Option (right to buy) | +12,320 | 12,320 | D | ||
| Parikh Anand Kiran President and CEO | 2026-02-17 | Grant or award · Employee Stock Option (right to buy) | +136,884 | 136,884 | D | ||
Loading xslF345X06/form4a-06162026_080634.xml…